石四药集团(02005) - 股东权益变动
最后更新于:2024-11-26
*注解:(L)- 好仓, (S)- 淡仓, (P)- 可供借出的股份。
全部购买出售
全部董事非董事
# | 日期 | 股东名称 | 披露原因 | 改变数量 | 成交均价 | 金额 | 持有权益的股份数量 | 占已发行的有投票权股份百分比 | 表格序号 |
---|---|---|---|---|---|---|---|---|---|
1 | 2024-11-26 | 曲繼廣 | 3.49港币 | DA20241126E00221 | |||||
2 | 2024-11-20 | 曲繼廣 | 3.88港币 | DA20241120E00155 | |||||
3 | 2024-11-19 | 曲繼廣 | 3.77港币 | DA20241119E00268 | |||||
4 | 2024-11-05 | UBS Group AG | 3.82港币 | CS20241108E00223 | |||||
5 | 2024-09-24 | 曲繼廣 | 3.87港币 | DA20240924E00216 | |||||
6 | 2024-09-02 | 曲繼廣 | 3.81港币 | DA20240902E00236 | |||||
7 | 2024-08-21 | 四川科倫藥業股份有限公司 | 3.54港币 | CS20240822E00129 | |||||
8 | 2024-04-17 | China Pharmaceutical Company Limited | 4.76港币 | CS20240417E00337 | |||||
9 | 2024-04-03 | 曲繼廣 | 5.01港币 | DA20240403E00330 | |||||
10 | 2024-03-28 | 曲繼廣 | 4.90港币 | DA20240328E00206 | |||||
11 | 2023-12-05 | 曲繼廣 | 4.74港币 | DA20231205E00224 | |||||
12 | 2023-07-11 | 曲繼廣 | 4.59港币 | DA20230711E00299 | |||||
13 | 2023-07-07 | 曲繼廣 | 4.40港币 | DA20230707E00308 | |||||
14 | 2023-05-09 | 曲繼廣 | 4.94港币 | DA20230509E00224 | |||||
15 | 2023-04-04 | 曲繼廣 | 4.61港币 | DA20230404E00250 | |||||
16 | 2023-03-29 | 曲繼廣 | 4.20港币 | DA20230329E00253 | |||||
17 | 2022-10-03 | China Pharmaceutical Company Limited | 3.30港币 | CS20221003E00225 | |||||
18 | 2022-08-11 | UBS Group AG | 3.89港币 | CS20220816E00228 | |||||
19 | 2022-08-05 | UBS Group AG | 4.07港币 | CS20220810E00288 | |||||
20 | 2022-06-30 | UBS Group AG | 4.22港币 | CS20220706E00441 |